Churchill utilizes SoluMatrix™ Fine Particle Technology™ to improve outcomes for patients with cancer.
Trusted, Effective, Successful.
Churchill Pharmaceuticals is focused on the development and commercialization of orally administered cancer medicines. We apply advanced technology which has successfully been utilized in three FDA approved products to improve drug effectiveness, reduce variability and help alleviate side effects.
Our most advanced oncology development program is for the treatment of genitourinary cancer.
Churchill is actively seeking partners for its development stage oral oncology drugs as well as opportunities to apply the SoluMatrix™ Fine Particle Technology™.
The Churchill team is passionately committed to improving the lives of cancer patients. We are currently adding to the team.